Malvern, PA, United States of America

Colleen Marano

This inventor holds 1 USPTO granted patent and 6 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Janssen Biotech, Inc.. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Colleen Marano. Retrieved from https://idiyas.com/inventor/colleen-marano

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Colleen Marano: Inventor in Biopharmaceutical Research.

Introduction

Colleen Marano is an inventor associated with Malvern, Pennsylvania, and Janssen Biotech, Inc. Her patent work concerns antibody-based treatment for ulcerative colitis.

Latest Patents

Marano is named on 1 patent: “Methods of Treating Moderately to Severely Active Ulcerative Colitis by Administering an Anti-IL12/IL23 Antibody.” The patent describes methods and compositions for treating moderately to severely active ulcerative colitis in patients who have not responded adequately to, or cannot tolerate, conventional or existing therapies. The described treatment uses intravenous and/or subcutaneous administration of an anti-IL-12/IL-23p40 antibody.

Career Highlights

Marano’s listed patent is associated with Janssen Biotech, Inc. and focuses on a therapeutic approach for patients with active ulcerative colitis who need alternatives to existing treatments.

Collaborations

Her listed coworkers include Hongyan Zhang and Christopher O’Brien, reflecting the collaborative nature of biopharmaceutical research and patent development.

Conclusion

Colleen Marano’s patent contribution centers on antibody-based treatment methods for moderately to severely active ulcerative colitis and is associated with Janssen Biotech, Inc.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…